$125 | Single User
$250 | Site License
$375 | Enterprise License

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

Published by Global Data: 05 Jul 2016 | 13290 | In Stock

Introduction

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corporation (Terumo) is a medical technology company. It manufactures and sells a wide range of medical care products including hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusions systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company conducts its operations in three divisions, namely, General Hospital business, Cardiac and Vascular business, and Blood Management business. Terumo conducts its operations through subsidiaries and associate companies in Japan, Europe, Americas and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Terumo Corporation Key Recent Developments

Sep 02, 2015: Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare

May 19, 2015: Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies

Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant

Apr 06, 2015: Terumo and Olympus Expand Interventional System Business Partnership

Mar 19, 2015: Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Terumo Corporation - Key Facts 6

    Terumo Corporation - Key Employees 7

    Terumo Corporation - Key Operational Employees 10

    Terumo Corporation - Major Products and Services 11

    Terumo Corporation - Medical Equipment Pipeline Products Data 13

    Terumo Corporation Pipeline Products by Equipment Type 13

    Terumo Corporation Pipeline Products by Development Stage 14

    Terumo Corporation - History 16

    Terumo Corporation - Company Statement 23

    Terumo Corporation - Locations And Subsidiaries 24

    Head Office 24

    Other Locations & Subsidiaries 24

    Joint Venture 28

    Section 2 – Company Analysis 29

    Terumo Corporation - Business Description 29

    Business Description - Blood Transfusion Products 29

    Blood Transfusion Products - Overview 29

    Blood Transfusion Products - Financials 29

    Business Description - Cardiac and Vascular Products 29

    Cardiac and Vascular Products - Overview 29

    Cardiac and Vascular Products - Financials 29

    Business Description - General Hospital Products 29

    General Hospital Products - Overview 29

    General Hospital Products - Financials 30

    Terumo Corporation - Corporate Strategy 31

    Terumo Corporation - SWOT Analysis 32

    SWOT Analysis - Overview 32

    Terumo Corporation - Strengths 32

    Strength - Improving Financial Position 32

    Strength - Cardiac and Vascular Franchise 32

    Strength - Strong Presence in International Markets 32

    Terumo Corporation - Weaknesses 33

    Weakness - Product Safety Concerns 33

    Weakness - Substantial Debt 33

    Terumo Corporation - Opportunities 34

    Opportunity - The US FDA 510(k) Clearances 34

    Opportunity - Increasing Cardiovascular Diseases 34

    Opportunity - Strategic Initiatives 34

    Terumo Corporation - Threats 36

    Threat - Rise in Raw Material Prices 36

    Threat - Intense Competition 36

    Threat - Rapid Technological Changes 36

    Threat - Stringent Government Regulations 36

    Terumo Corporation - Key Competitors 37

    Section 3 – Company Financial Ratios 38

    Financial Ratios - Capital Market Ratios 38

    Financial Ratios - Annual Ratios 39

    Performance Chart 41

    Financial Performance 41

    Financial Ratios - Interim Ratios 42

    Financial Ratios - Ratio Charts 43

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 44

    Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 44

    Terumo Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016 45

    Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 46

    Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 47

    Terumo Corporation, Recent Deals Summary 48

    Section 5 – Company’s Recent Developments 49

    Jun 10, 2016: FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility 49

    Mar 02, 2016: NICE recommends new sickle cell treatment device that could save the NHS millions 50

    Sep 02, 2015: Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare 51

    Jul 01, 2015: OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo 52

    Jun 01, 2015: MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo 53

    Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 54

    Apr 06, 2015: Terumo and Olympus Expand Interventional System Business Partnership 55

    Apr 02, 2015: Terumo announces CE mark approvals for LIFEPEARL and HYDROPEARL microspheres 56

    Mar 19, 2015: Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices 57

    Feb 12, 2015: Terumo Establishes a New RD Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area 58

    Section 6 – Appendix 59

    Methodology 59

    Ratio Definitions 59

    About GlobalData 63

    Contact Us 63

    Disclaimer 63

List Of Tables
in Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

List of Tables

Terumo Corporation, Key Facts 6

Terumo Corporation, Key Employees 7

Terumo Corporation, Key Operational Employees 10

Terumo Corporation, Major Products and Services 11

Terumo Corporation Pipeline Products by Equipment Type 13

Terumo Corporation Number of Pipeline Products by Development Stage 14

Terumo Corporation Pipeline Products Summary by Development Stage 15

Terumo Corporation, History 16

Terumo Corporation, Other Locations 24

Terumo Corporation, Subsidiaries 25

Terumo Corporation, Joint Venture 28

Terumo Corporation, Key Competitors 37

Terumo Corporation, Ratios based on current share price 38

Terumo Corporation, Annual Ratios 39

Terumo Corporation, Interim Ratios 42

Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 44

Terumo Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016 45

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 46

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 47

Terumo Corporation, Recent Deals Summary 48

Currency Codes 59

Capital Market Ratios 59

Equity Ratios 60

Profitability Ratios 60

Cost Ratios 61

Liquidity Ratios 61

Leverage Ratios 62

Efficiency Ratios 62

List Of Figures, Charts and Diagrams
in Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

List of Figures

Terumo Corporation Pipeline Products by Equipment Type 13

Terumo Corporation Pipeline Products by Development Stage 14

Terumo Corporation, Performance Chart (2012 - 2016) 41

Terumo Corporation, Ratio Charts 43

Terumo Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 44

Terumo Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 45

Terumo Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 46

Terumo Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 47

Additional Details

Publisher

Global Data

Publisher Information

Reference

13290 | GDME740FSA

Number of Pages

63

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Terumo Cardiovascular Systems Corporation - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Cardiovascular Systems Corporation (TCSC) is a provider of medical equipment and devic...
14 Apr 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
14 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
13 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
12 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
10 Mar 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
09 Mar 2016 by Global Data USD $250 More Info
Terumo Cardiovascular Systems Corporation - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Cardiovascular Systems Corporation (TCSC) is a provider of medical equipment and devic...
24 Feb 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
24 Feb 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
24 Feb 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Strategic SWOT Analysis Review
Terumo BCT, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’...
23 Feb 2016 by Global Data USD $125 More Info

This report is published by Global Data

Download Free Report Summary PDF

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data